Drawing for S-TENSIFY

USPTO serial 79414132

S-TENSIFY

Reviewed by CopyMark Law Group

Reg. 8016882Status 700Registered
Filing date
Status date
Registration date
Nov 11, 2025
Examiner
CROSS, TRACY L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with S-TENSIFY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian P. Gregg

Brian P. Gregg McNees Wallace & Nurick100 Pine StreetHarrisburg, PA 17108United States

Goods and services

ClassDescriptionStatusFirst use
040Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of pharmaceuticals; custom manufacture of specific antibody-binding glycosylation drugs; processing of chemicals.ACTIVE—
042High-efficiency scientific laboratory service for glycan analysis; culturing of cells for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid analysis; protein analysis; toxicity analysis; scientific research in the field of molecular biology; development of biotechnology; biotechnological research; scientific research in the field of biological analysis; biological research; scientific research in the field of biologics; scientific research in the field of biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research on the subject of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; testing services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; scientific research in the field of genetic research; computer programming in the medical field; medical research laboratories; programming of software for importing and managing medical image data; medicine research; analysis and evaluation of medical product development; providing information on the testing, inspection and research of medical products; providing medical and scientific research information in the field of clinical trial progress; scientific research in the nature of conducting clinical trials for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 18, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 1, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 31, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 29, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 29, 2026FIMPFINAL DISPOSITION PROCESSED—
Feb 11, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 23, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 23, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 19, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 19, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 19, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 10, 2025RFNTREFUSAL PROCESSED BY IB—
Apr 19, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 19, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 12, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2025DOCKASSIGNED TO EXAMINER—
Jan 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance